510(k) Report

510(k) · Cleared

Cleared

Immulite Pyrilinks-D

K971312510(k) TraditionalCleared May 27, 199748-day reviewClass I21 CFR 862.1400

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Diagnostic Products Corp. · JMM Column Chromatography & Color Development, Hydroxyproline

Cleared on May 27, 1997 as substantially equivalent to K952320 (Metra Biosystems, Inc., 1995) after a 48-day review. Its family tree reaches back 1 generation to 1995.

Decided
May 27, 1997
Review
48 days
Class
Class I
Product code
JMM
Recalls
None
Predicates
1

Its longest line of descent runs back 1 generation to K952320 (1995). No later device cites it as a predicate yet.

K952320 · Pyrilinks-D Assay Kit · Metra Biosystems, Inc. · 199519961998
K952320 · Pyrilinks-D Assay Kit · Metra Biosystems, Inc. · 19950
  1. Root · 1 generation backK952320 Pyrilinks-D Assay KitMetra Biosystems, Inc. · 1995
  2. This deviceK971312 Immulite Pyrilinks-DDiagnostic Products Corp. · 1997
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−1K952320Pyrilinks-D Assay KitMetra Biosystems, Inc.1995—
0 (this device)K971312Immulite Pyrilinks-DDiagnostic Products Corp.1997—
FIG. 1 — Lineage of K971312, 1995–1997Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in JMM? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

  • Candidate predicates for a device like this, rankedin the report
  • Recall history across each candidate’s familyin the report
Get a 510(k) Report

What was it cleared against? (1)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*K952320Pyrilinks-D Assay Kit
Summary page 1
…tests Diagnostic Products Corporation 5700 West 96th Street Los Angeles, California 90045-5597 DPC's Registration Number 1s 2017183 Metra Biosvstemns® Pynilinks®-D (K952320) IMMULITE? Pyrilinks®-D is a clinical device for use with the IMMULITE® Automated Immunoassay Analyzer The IMMULITE® Pyrilinks®…
Metra Biosystems, Inc.1995—

What descends from it?

No later submission names this one as a predicate yet.

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • Its one ancestor has no recall.

How does its category compare?

All JMM devices

JMM Column Chromatography & Color Development, Hydroxyproline: FDA decisions, review times, recalls and adverse event reports over 20 years.

FDA decisions per year · JMM

FDA has decided no JMM device since 2007.

Median 510(k) review, days · JMM

Too few JMM 510(k)s in any year since 2007 to give a median.

Recalls per year · JMM

1in 2012

2012: 1
2007high 1 (2012) · low 0 (2007)2026

Class I (0 since 2007) Class II/III not classified

Adverse event reports per year · JMM

1in 2025

2019: 12021: 12023: 12024: 12025: 1
2007high 1 (2019) · low 0 (2007)2025

MAUDE reports naming product code JMM, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20070—00
20080—00
20090—00
20100—00
20110—00
20120—10
20130—00
20140—00
20150—00
20160—00
20170—00
20180—00
20190—01
20200—00
20210—01
20220—00
20230—01
20240—01
20250—01
20260—0—

What is it indicated for?

DPC's IMMULITE® Pyrilinks®-D is a solid-phase, chemiluminescent enzyme immunoassay for use with the IMMULITE® Automated Analyzer and is designed for the quantitative measurement of deoxypyridinoline (DPD) in urine. It is intended strictly for in vitro diagnostic use as an indicator of bone resorption.

Indications for use read by OCR from a scanned FDA summary, so letters may be misread. Check the PDF before quoting it.

Cite this page

510(k) Report. “K971312: Immulite Pyrilinks-D.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 6, 2026. https://510kreport.com/device/K971312

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026